Support Alert

Drug safety update: Pseudoephedrine and ephedrine

10 Sep 2015

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a drug safety update highlighting how implementation of measures to regulate sales, together with the additional voluntary actions overseen by the pharmacy profession, has made an important contribution to managing the risk of misuse of pseudoephedrine and ephedrine in the UK. The recommendation is that existing levels of monitoring, education and awareness measures by pharmacists should be maintained.

Further details of the update are available on the MHRA website.